Pharmaceutical company Galderma has been announced as Headline Sponsor for the Clinical Cosmetic Regenerative Congress (CCR) 2026.
Galderma will have a presence across the scientific programme and exhibition floor, providing delegates with opportunities to engage with the company’s portfolio, clinical data and educational initiatives.
As Headline Sponsor, Galderma will support key elements of the educational programme, including faculty-led sessions and live demonstrations, with an emphasis on evidence-based protocols and real-world treatment planning. Galderma’s continued partnership with CCR highlights the event’s role as a key platform for practitioner education and field engagement, as well as a space for delegates to connect directly with specialty leaders on evolving practice trends, patient expectations and the wider regulatory landscape ahead of the 2026 event.
Speaking at the Aesthetics Journal Arena, Galderma will focus on menopause on Day 1, with Day 2 dedicated to skin and lips, skin boosters and ALASTIN. The company’s presence will also spotlight its portfolio, including Restylane, Sculptra and ALASTIN. Confirmed speakers include Dr Yusra Al-Mukhtar, Dr Jessica Halliley and nurse prescriber Mary Irving.